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IntroductIon
The placenta serves as the maternal-foetal interface during pregnancy and is one of the main determinants of pregnancy course and outcome. It also functions as an endocrine organ and plays a major role in maternal adaptation to pregnancy and foetal growth and development (124, 125) . Pre-eclampsia (PE) is a multiorgan disorder in which impaired placental functioning due to excessive oxidative stress is involved (1). PE can affect the maternal liver, kidneys, brain and clotting system and is often complicated with foetal growth restriction (FGR) and preterm birth (PTB).
The internal body clock is of main importance in the regulation of the metabolic and hormonal states during reproduction and pregnancy (126) (127) (128) (129) . All tissues and cells, including the placenta, have a circadian clock, which is kept synchronous by the master clock (130, 131) . The circadian clock imposes 24-hour rhythmicity of behavior, physiology, and metabolism. The mammalian circadian system is regulated by the circadian master clock, located in the suprachiasmatic nuclei and receiving light input from the retina to keep synchrony with the light-dark cycle. Evidence is accumulating that circadian misalignment significantly impacts pregnancy and health during the life course (132). Recent reports, studying women working night shifts (in services such as healthcare, military, protection and airway), show associations between disrupting the light-dark cycle during pregnancy and a higher risk of PTB, low birth weight, spontaneous abortion and subfertility (133) (134) (135) . So far, however, only a few data are available on associations between alterations of the circadian rhythm and PE (136) (137) (138) (139) . In this regard of interest is the hormone melatonin, which is regulated by the circadian clock and synthesized by the placenta thereby protecting against excessive oxidative stress involved in the pathogenesis of PE. (129, 140, 141) . Epigenetic mechanisms implicated in foetal and placental development can explain associations between PE and increased risks of features of noncommunicable diseases in mothers and children (14) (15) (16) 142) . Altered DNA methylation patterns are found in placental tissues of PE and are associated with maternal blood pressure and excessive oxidative stress (143) . Approximately 10% of the transcriptome is under circadian regulation, and, at the molecular level, the circadian oscillator is composed of a set of clock genes that act in interconnected transcription/translation feedback loops (144, 145) (see Figure 1 for a schematic overview of the regulation of the molecular clock). ARNTL (also known as BMAL1) and CLOCK are the positive activators and drive the transcription of clock genes by binding to E-box elements on their promoters. PER and CRY inhibit the specific transcription activation by ARNTL and CLOCK, thereby forming a negative feedback loop. An additional loop is formed by NR1D1 (also known as Rev-Erbα), which represses ARNTL transcription. The period length of the circadian clock cycle is fine-tuned by posttranslational modifications, such as phosphorylation and ubiquitylation, that regulate clock protein stability.
From this background, we hypothesize that PE is associated with alterations in tissuespecific epigenetic programming of circadian clock (controlled) gene loci in placental and newborn tissues. The objective of our study was to examine the DNA methylation of circadian clock and clock-controlled genes in the placenta, umbilical cord leukocytes (UCL) and human umbilical vein endothelial cells (HUVEC) in relation to PE. Because of clear differences in pathophysiology, we selected a group of early-onset PE (EOPE, onset <34 weeks of gestation) and late-onset PE (LOPE, onset ≥34 weeks of gestation) (37, 146) . In addition, because PE is often complicated with FGR and PTB, conditions known to also affect epigenetic programming, we investigated the DNA methylation of PE in comparison with non-PE controls, FGR and spontaneous PTB as additional non-PE control groups.
MAterIAl And Methods

study design
A nested case-control study was conducted and embedded in the Rotterdam Periconceptional Cohort (Predict Study), a prospective tertiary hospital-based study of the Department of Obstetrics and Gynecology, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands (147). The study has been approved by the local Medical Ethical and Institutional Review Board of the Erasmus University Medical Centre (MEC-2004-227) . At enrolment, all participants signed written informed consent before participation.
Patients with EOPE and LOPE were enrolled as well as controls without PE. Controls were divided in three different study groups: uncomplicated controls (CTRL), pregnancies complicated by FGR and pregnancies complicated by spontaneous PTB. The rational is that EOPE often results in PTB and FGR, and including these complicated pregnancy study groups provides the opportunity to compare EOPE with pregnancies of a comparable gestational age and birth weight.
PE was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on at least two occasions 4 hours apart after 20 weeks of gestation with proteinuria (protein/creatinine ratio of ≥30 mg/mmol). EOPE was defined as the onset of the disease <34 weeks of gestation (37, 146) . FGR was defined as a birth weight below the 10 th percentile.
Patients were included based on the estimated foetal weight of ultrasound measurements during pregnancy. This was validated with a birth weight below the 10 th percentile according to the reference curves of the Dutch Perinatal Registry. PTB was defined as delivery before 37 weeks of gestation. CTRL were pregnancies without PE, gestational hypertension, FGR or PTB. Clinical data were obtained from questionnaires and medical records.
sample collection and dnA extraction UCL: Umbilical cord blood was collected in anticoagulant vacutainer tubes (ethylenediaminetetraacetic acid) and processed within 48 hours after delivery to determine white blood cell count and differentiation and to store the isolated total white blood cell pellets at -80 degrees Celsius C until DNA extraction. Prior to DNA extraction, thawed UCL were subjected to erythrocyte lysis by use of Erythrocyte Lysis Buffer (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Placental tissue: After removal of the membranes and 2 mm of the top placental layer, placental biopsies (0.5 cm 3 ) were taken at four different sites of the foetal side of the placenta in a radius of 3 cm around the umbilical cord insertion. Samples were washed in phosphate buffered saline solution (PBS), frozen in liquid nitrogen and stored at −80 degrees Celsius C until DNA extraction. Placental tissue (30 mg) was grinded manually on dry ice. The obtained frozen powder was immediately added to lysis buffer and stored at −80 degrees Celsius C until further processing. HUVEC: The umbilical cord vein was rinsed with cord buffer once and all umbilical cord blood was removed, filled with collagenase solution (1 mg/mL). After incubation for 15 min in a PBS water bath (37 degrees Celsius C), detached HUVEC were obtained and purified by magnetic-activated cell separation (MACS) with CD146 MACS MicroBeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). HUVEC pellets were frozen in liquid nitrogen and stored at −80 degrees Celsius C until DNA extraction.
The collection and storage process was done in a standardized way by trained researchers. Genomic DNA was extracted from all tissues using the Allprep DNA/RNA isolation mini kit (Qiagen, Hilden, Germany), using the manufacturer's protocol, and quantified using absorbance spectrometry.
dnA methylation measurement and pathway driven gene selection
Isolated DNA (500 ng) was treated with sodium bisulfite using the EZ-96 DNA methylation kit (Shallow Well Format) (Zymo Research, Irvine, CA). DNA methylation was measured by using Illumina HumanMethylation450K BeadChip. The methylation module of GenomeStudio (Illumina Inc., San Diego, CA) was used to check the performance of built-in quality controls in the Control Dashboard. CpGs located on the X-chromosome and CpGs containing known single nucleotide polymorphisms were excluded from analysis (148). Data were normalized by using the Dasen procedure. Methylation β-values were converted to M-values (M-value = log 2 [β-value/(1-β-value)]). To achieve a pathway-driven analysis of DNA methylation at circadian clock (controlled) gene loci, a total of 39 genes were selected (Figure 3 ). This included core clock genes, clock-controlled genes, as well as output genes. Considering that PE is associated with metabolic derangements, we especially focused on output genes that are involved in metabolic processes or that have been shown to have a link with the circadian clock and metabolic queues, such as insulin or glucose levels (150)(150) (147) (147)(147)(147)(147)(147)(147)(146) , (151, 152) . As shown in Figure 3 , for these 39 genes there are 939 CpGs present in the Illumina 450K array. These CpGs are distributed across the gene loci and are present in CpG-islands around the transcription start, at gene body and at regulatory regions such as the 5'-and 3'-UTR. 
results clinical characteristics
DNA methylation data were available of a total of 114 pregnancies. Exclusion of two pregnancies, which did not meet the inclusion criteria, resulted in a total sample of 112 pregnancies, consisting of 13 patients with EOPE, 16 patients with LOPE, 36 uncomplicated controls, 27 pregnancies complicated by FGR and 20 by spontaneous PTB. In Table 1 , maternal and newborn characteristics are shown. In line with the selection criteria, blood pressure, gestational age and birth weight differed between PE and (un)complicated control groups.
Patients with EOPE and LOPE were more often nulliparous compared to uncomplicated controls (respectively 84.6% and 81.3%, versus 30.6%, p = 0.001). In the EOPE group, more pregnancies were terminated by cesarean section compared to all other groups. Regarding the newborn characteristics, there were no significant differences in gender between the study groups. Gestational age and birth weight differed between all study groups. Although gestational age was still lower in EOPE compared to spontaneous PTB, these two groups were most comparable in gestational age.
Identification of dMcs between all study groups
As shown in Figure 4 , we found significant differences in CpG methylation of clock (controlled) genes in all analyzed tissues. The number of DMCs was tissue-specific and most DMCs were found in UCL (n = 31), followed by placenta (n = 7) and HUVEC (n = 1).
comparisons of eoPe and loPe versus (un)complicated controls (Figure 5)
EOPE significantly differed from spontaneous PTB at six clock (controlled) CpGs in placental tissue, of the genes: AKT1 (p = 8. While in the overall analysis one DMC was found in HUVEC, we found no DMCs in HUVEC when comparing EOPE and LOPE to all other study groups. This indicates that the DMCs identified with the overall analysis represent differences between control groups. Also no DMCs were found in LOPE. In Figure 6 , absolute methylation levels are shown for the different groups at different gestational ages. 
Data represented as mean (± standard deviation) with corresponding ANOVA testing to examine overall differences between EOPE, LOPE, CTRL, FGR and PTB, followed by the post hoc Dunnett t-test for pairwise comparisons versus both EOPE and LOPE. Data represented as number (%) with corresponding Chi
dIscussIon
We established tissue-specific alterations in methylation of circadian clock genes in EOPE compared to uncomplicated controls, FGR and spontaneous PTB, but not in any comparison with LOPE. In EOPE compared to spontaneous PTB, we identified in placental tissue DMCs in circadian clock-controlled genes, but not in the circadian core clock genes. In particular, the identification of DMCs in AKT1 and PRDX1 is in line with the oxidative stress imbalance in the placenta (Figure 1 shows the function of these genes). However, in UCL we identified DMCs in the circadian core clock genes ARNTL, CLOCK (and NPAS2, a CLOCK homolog in some tissues), CRY2 and PER2 in EOPE compared to spontaneous PTB. These genes are necessary for circadian clock function and changes in expression have been associated with noncommunicable diseases, such as metabolic disease and cancer (153, 154) .
The most distinct differences were observed in EOPE compared to spontaneous PTB. Gestational age was most comparable between these two groups, which strengthens the hypothesis that PE is associated with differential methylation itself without confounding by gestational age. This is clearly demonstrated in the right part of Figure 6 , where absolute DNA methylation levels in EOPE, LOPE and (un)complicated control groups are depicted at the gestational age of sampling. No differential methylation was observed between LOPE and all other (complicated) control groups. The epigenetic landscape is formed in particular during the periconceptional period and mainly during the first days after conception, supporting the evidence that LOPE largely develops after this period. The alterations in methylation as a memory of exposures in EOPE substantiate the first trimester origin of this PE phenotype. EOPE and LOPE are likely to reflect different underlying biological mechanisms, often indicated as the placental versus the metabolic syndrome (4).
Previous research showed that clock gene expression can be enhanced by hypoxia in human trophoblast cells in vitro (155), (135). Intermittent placental perfusion, caused by deficient trophoblast invasion of the endometrial arteries, can result in hypoxia-reoxygenation injury. The fluctuation in oxygen concentrations can cause excessive placental oxidative stress and as such alter the establishment of the epigenetic methylation markers (156). This is in line with our finding that in EOPE most DMCs were hypomethylated in placental tissue and hypermethylated in UCL and substantiated by other epigenetic studies of candidate genes in PE (157), (158-160), (161).
The opposite direction of methylation in placental tissue and UCL might be explained by differences in tissue sensitivity and the level of exposure. Although an important question is whether the observed changes in DNA methylation result in changes in gene expression, the current data cannot answer this question. Nevertheless, it is noteworthy that the same type of CpGs within a gene (i.e. promoter, body) show methylation changes in the same direction as the identified DMCs, although the differences are not significant (not shown).
Although DNA methylation is considered to be mostly stable, there is a recent study showing that a number of CpGs show circadian oscillation in DNA methylation in mouse liver (162). In order to exclude a possible effect of the time of delivery, we performed an additional statistical analysis in which we did a sensitivity analysis for the time of delivery (supplemental figure, Figure S1 ). This did not affect the majority of the DMCs identified in the present study, indicating that time of delivery is not a confounding factor in our study.
epigenetics and health of the offspring
In this study, we hypothesized that PE may be associated with changes in DNA methylation of circadian clock gene loci and leave epigenetic marks during pregnancy in newborn tissues. Alterations in DNA methylation of circadian clock and clock-controlled genes may be a consequence of a situation of excessive oxidative stress during exposure to this disorder. However, either cause or consequence, we showed in this study that an altered methylation level was present in some clock (controlled) genes in placental and foetal tissues after EOPE. This suggests that the epigenome of EOPE offspring might be affected as well. This is supported by our observation that differential methylation is higher in UCL than in placenta, suggesting that the alterations observed in placenta further induced epigenetic alterations in UCL (as a consequence of an imbalanced cellular environment due to placental malfunctioning and excessive oxidative stress). This is in line with the Developmental Origins of Health and Disease (DOHaD) paradigm (142). Unfortunately, we were not able to study DNA methylation of the offspring after follow-up. For future research, it is essential to validate these findings with data of the transcriptome and subsequently to measure DNA methylation and expression levels in these children and monitor the functioning of their circadian clock.
strengths and limitations
As far as we know, this is the first study investigating DNA methylation of circadian clockcontrolled genes in unique homogeneous study groups of EOPE and LOPE cases, and spontaneous PTB, FGR and uncomplicated controls. We were able to study three different tissues in most pregnancies collected in a standardized and high-quality manner. The external validity of the study is limited which is inherent to the tertiary hospital setting in which the study was performed. Moreover, the small number of samples, in particular of HUVEC, and the heterogeneity of cell types in placental tissues remain issues of potential bias (163, 164) . Another limitation is that we do not have information about the circadian clock and light exposure of the participants to test for correlations with the results..
conclusion
DNA methylation status of circadian clock and clock-controlled genes in placental tissue and UCL is different between patients with EOPE and non-PE controls. This may be explained by a longer exposure to placental oxidative stress as compared to pregnancies complicated by LOPE. For future research, it would be interesting to study whether these DNA methylation alterations affect long-term health and circadian performance in the offspring.
